Purpose. Based on a unique phase alignment that occurs during formulation, we postulated that PEGylation of the cargo enzyme would enhance its encapsulation within diblock copolymer nanocarriers and thus resistance to proteases. Methods. A freeze-thaw modified double emulsion technique was utilized to encapsulate either the catalytically active enzyme catalase (MW ∼250 kDa) or PEG-catalase in PEG-PLA polymer nanocarriers (PNC). Spectrophotometer measurement of substrate depletion was utilized to monitor enzyme activity. Isotope labeling of the enzyme was used in conjunction with activity measurements to determine PNC loading efficiency and PNC-enzyme resistance to proteases. This labeling also enabled blood clearance measurements of PNC-loaded and non-loaded enzymes in mice. Results. Non-loaded PEG-catalase exhibited longer circulation times than catalase, but was equally susceptible to proteolysis. Modulation of the ratio of relatively hydrophilic to hydrophobic domains in the diblock PEG-PLA copolymer provided either filamentous or spherical PNC loaded with PEG-catalase. For both PNC geometries, encapsulation and resistance to proteases of the resultant PNC-loaded enzyme were more effective for PEG-catalase than catalase. Isotope tracing showed similar blood levels of PNCloaded and free PEG-catalase in mice. Conclusions. PEGylation enhances active catalase loading within PNC and resistance to protease degradation, relative to unloaded PEG-catalase.
INTRODUCTION
Premature elimination from circulation, as well as inactivation by inhibitors and proteases, limit the effectiveness and utility of therapeutic enzymes. Coating with relatively hydrophilic poly (ethylene glycol) (PEG) prolongs circulation and reduces recognition of therapeutics and their carriers by defense systems (stealth technologies) (1) (2) (3) . On the other hand, affinity targeting improves site-specific localization and drug efficacy. For example, through conjugation of an affinity antibody, targeting catalase (an antioxidant enzyme that dissociates the reactive oxygen species H 2 O 2 into water and oxygen) to endothelial cells lining the blood vessel lumen alleviates vascular oxidative stress in animal models (4) (5) (6) (7) . However, targeted catalase-antibody conjugates traffic to lysosomes and are degraded by proteases within a few hours, terminating therapeutic effectiveness (8) .
Therapeutic enzymes can be encapsulated within stealth polymer nanocarriers (PNC) in order to limit access to and degradation by lysosomal proteases (9, 10) . Inactivation of labile enzymes is a main challenge of PNC encapsulation (11, 12) . However, a double emulsion technique that involves a freeze-thaw cycle permits encapsulation of diverse, catalytically active enzymes including catalase (a large, MW ∼250 kDa, highly labile tetrameric enzyme) into PEG-poly(lactic acid or lactic-co-glycolic acid) (PEG-PL(G)A) PNC (11, 13) . These PNC have diameters on the order of 300 nm that permit vascular administration. The catalase substrate, H 2 O 2 , diffuses through cell membranes and the PNC polymer materials with similar kinetics (14) . Therefore, PNC act as a protective cage for the encapsulated enzyme, capable of sustained therapy without the need for drug release (11, 13) . Ex vivo perfused lung studies showed that targeting PNC-encapsulated catalase (antibodies conjugated directly to the PNC) to the endothelium provides sustained augmentation of antioxidant defense and protection against vascular oxidative stress (13). Therefore, further investigation and optimization of this promising approach represent an important biomedical goal.
Of particular interest from this standpoint, Fig. 1 illustrates a unique phase alignment of the amphiphilic diblock copolymer PEG-PLA that occurs during the modified double emulsion at the oil/water interface (15) . This phase separation is enhanced by the initial, primarily organic phase emulsion and the sharp temperature transition utilized in this formulation step (−80°C freeze-thaw). The relatively hydrophilic PEG block of the copolymer will preferentially distribute into the proportionately small fraction aqueous phase (primary emulsion is 90% oil phase) that contains protein due to PEG's ability to form hydrates with water, especially upon negative temperature transitions (16, 17) . It has also been shown that in addition to the formation of inverse micelles, PEG can enhance solubility in an oil phase, and this may further assist PNC loading of a protein in a w/o/w emulsion (18) . Most likely, this effect will be proportional to a protein's hydrophilicity, which in turn, can be enhanced by its PEGylation. These considerations suggest that PEG-catalase may preferentially partition into PEG cores of the initial emulsion stabilized by the negative temperature transition (Fig. 1B) . This would be an important advantage over the current double emulsion approach in which catalase encapsulation into PNC is associated with surface deposition of a significant fraction of the enzyme that is not protected from proteases (11, 15) .
The goal of this study was to test whether catalase replacement by PEG-catalase enhances the encapsulation efficiency and minimizes the surface accessible enzyme fraction in PEG-PLA PNC. Furthermore, we have reported recently that an increase of the hydrophobic PLA molecular weight fraction in the diblock PEG-PLA copolymer over 80% leads to formation of filamentous catalase-loaded PNC, while lower PLA content yields spherical carriers (15) . Therefore, in this study we also examined PEG-catalase loading into morphologically different PNC. We characterized PNC/PEG-catalase drug delivery systems in terms of protein loading, morphology, activity and susceptibility of loaded enzyme to protease degradation, and circulation in vivo in a mouse model.
MATERIALS AND METHODS

Reagents
All chemicals and reagents, including PEG-catalase, were purchased from Sigma-Aldrich (St. Louis, MO, USA) and used as received unless otherwise stated. Methoxy-PEG (mPEG) MW 5,000 was purchased from Polysciences (Warrington, PA, USA). Catalase from bovine liver and horseradish peroxidase were purchased from Calbiochem (EMD Biosciences, San Diego, CA, USA). Uranyl acetate was acquired from Electron Microscopy Sciences (Fort Washington, PA).
Synthesis of Diblock Copolymers
DL-lactide was precipitated twice into anhydrous diethyl ether, before mixing with mPEG in stoichiometric ratios to achieve desired molecular weights. Reactants were purged with dry nitrogen and sealed in a round bottom flask before heated to 140°C while stirring for 2 h to remove trace water from samples. The temperature was reduced to 130°C and stannous octoate (1 wt.%) was added to catalyze the ring opening polymerization (ROP) of lactide with mPEG serving as the initiator. The polymerization was allowed to continue for 6 h. The diblock copolymer was then dissolved in DCM and twice precipitated in cold diethyl ether. Residual solvent was then removed by first drying via rotary evaporation (Safety Vap 205, Buchi, Switzerland), followed by lyophilization (VirTis BenchTop SLC, SP Industries, Gardiner, NY, USA).
Number average molecular weights M n À Á of bulk copolymers were determined using proton nuclear magnetic resonance ( 1 H-NMR). The weight average molecular weights M w À Á and polydispersity indices (PDI) were also determined by gel permeation chromatography (HPLC-GPC), with a Binary HPLC pump (1525, Waters, Milford, MA, USA), a Refractive Index Detector (2414, Waters) and three serial 7.8×300 mm Styragel columns (Waters) using tetrahydrofuran (THF) as the mobile phase. Chromatograms were analyzed using Breeze version 3.3 software with polystyrene standards used for calibration.
Diffusivity of Hydrogen Peroxide Through PEG-PLA
The diffusivity of H 2 O 2 through PEG-PLA was determined with a two diffusion chamber apparatus, as described before (19) . Briefly, for each experiment, a new thin polymer film was cast and the thickness measured, before placement between two chambers, the donor containing the substrate, 5 mM H 2 O 2 in pH 7.4 50 mM phosphate buffered saline (PBS), and the receptor containing simply 50 mM PBS. The two-cell apparatus was maintained at physiologic temperature. The concentration of H 2 O 2 in the receptor compartment was determined as a function of time by measuring UV absorbance at 242 nm (Cary 50 UV-Vis, Varian, Palo Alto, CA, USA).
Nanoparticle Formation
A freeze-thaw double emulsion solvent evaporation technique was used as previously outlined (11) . Briefly, mPEG-PLA diblock copolymer is dissolved in DCM at 25 mg/ml. A 1 mg/ml catalase, or PEG-catalase (PEG M n ¼ 5; 000 , ∼40 PEG molecules per protein molecule according to supplier) solution and a PVA surfactant solution (2 wt.%, 87-89% hydrolyzed, M w ¼ 13; 000 À 23; 000 ) in 20 mM PBS are prepared. The primary emulsion consists of the organic phase (1 ml polymer-DCM mixture) and the aqueous phase (100 μl catalase solution) homogenized at 15,000 rpm for 1 min in a dry ice-acetone bath with a 7 mm-blade homogenizer (Kinemetica Polytron 3100 with a PDTA3007/2 generator, Brinkmann Instruments, Westbury, NY, USA). The primary emulsion is then added to 5 ml of the PVA surfactant solution and homogenized at 15,000 rpm for 1 min. The resultant mixture is added to 10 ml of PVA solution and stirred overnight to allow removal of the residual solvent. The microparticle fraction is removed by a primary centrifugation at 1,000×g for 10 min. The nanoparticle fraction is collected by subsequent centrifugation at 20,000×g for 30 min. The supernatant is then removed and the PNC pellet is re-suspended in PBS and purified again by further centrifugation. White circles are protein, and white circles with concentric outer light gray ring are PEGylated catalase. Black dotted background is the organic phase of the primary emulsion, and black slashed background is the aqueous surfactant secondary emulsion phase. In theory, during this freeze-cycle, the primary emulsion, 90% organic phase/10% aqueous phase, consists of inverse micelles of the amphiphilic diblock PEG-PLA copolymer with a PEG-core containing the hydrophilic enzyme. Thus we hypothesized that PEGylated proteins would preferentially distribute within these PEG cores, stabilized by the −80°C cycle. Furthermore, it is known that negative temperature transitions favor the formation of PEG hydrates and thus PEGylated catalase loading should benefit from the phase alignment of this synthesis scheme. For the therapeutic effect without cargo release, the key parameter is that the enzyme substrate (H 2 O 2 ) diffuses freely through the PNC matrix (G). Diffusivity of substrate through polymer material is determined via a two chamber diffusion experiment, results of which are depicted (H). The diffusivity, or permeability coefficient, D, is the slope of the flux curve.
Enzyme Loading Determination
Protein loading was determined via radioisotope labeling and enzymatic activity. Loading via radiolabeling was determined as described before, by formulating PNC with To determine loading via enzymatic activity, a catalase activity assay (20,21) was used, both for the total sample before and after centrifugation. Briefly, 990 μl of 5 mM H 2 O 2 in PBS and 10 μl of enzyme-loaded PNC was added to a quartz cuvette. The kinetics of H 2 O 2 degradation was then measured with a spectrophotometer at 242 nm (absorbance at this wavelength corresponds to the H 2 O 2 concentration and thus catalase activity, U/mg=23.0(ΔA 242 /min) per milligram of catalase).
Catalase Protection Against Proteolysis
Protection against proteolysis was tested as described previously (11) . Briefly, PNC preps loaded with 125 I-catalase were incubated with a 0.2 wt.% pronase solution at 37°C in a shaker bath set at 60 rpm for 1 h. Samples were removed and centrifuged at 16,000×g for 20 min. Supernatant containing degraded protein and pellet containing intact protein encapsulated within PNC were collected and counted. This measure correlates linearly with preservation of enzymatic activity (11, 13) .
PNC Size Determination
Size was determined via dynamic light scattering (DLS, 90Plus Particle Sizer, Brookhaven Instruments, Holtsville, NY, USA) as described previously (11, 15) .
PNC Concentration Determination
PNC yield was determined by a colorimetric assay based on the detection of lactic acid monomer (22) . PEG-PLA samples were hydrolyzed to their monomer state with 5 M NaOH at 80°C overnight and neutralized with 5 M HCl. One ml of 20 wt.% CuSO 4 was added to a 1 ml aliquot of the hydrolyzed sample, alongside standards of known concentrations of lactic acid to construct a calibration curve. Samples were diluted to 10 ml, before addition of 1 g of dry Ca(OH) 2 . After incubation at room temperature for 30 min, samples were centrifuged at 1,000 g for 5 min and 1 ml aliquots of the supernatant were taken. 50 μl of 4 wt.% CuSO 4 and 6 ml of sulfuric acid were sequentially added before incubation at 100°C for 5 min. Samples were subsequently cooled to room temperature and 100 μl of p-hydroxydiphenyl in 0.5 wt.% NaOH was added before a 30 min incubation at 30°C. Next, the samples were heated to 100°C for 90 s to dissolve excess hydroxydiphenyl. Once the samples cooled to 25°C, the lactic acid concentration was determined with a spectrophotometer at 560 nm.
PNC Morphology Study
PNC morphology was characterized by fluorescence microscopy, transmission electron microscopy (TEM), and scanning electron microscopy (SEM). For fluorescence microscopy, aliquots of PNC were stained with the lipophilic carbocyanine dye, PKH26, via established methods (15, 23) and then imaged with a Nikon fluorescence microscope equipped with a ×60 oil immersion objective. For TEM, samples were prepared as previously described (15 I-PEG-catalase were also injected. Blood was drawn in 100 μl aliquots at specified increments from 1 min to 3 h by retro-orbital bleeding. At the end of the experiment, mice were sacrificed and harvested organs were washed, weighed and radioactivity measured. Five mice per experimental group were tested. Statistical significance was tested in all studies via a t test, where p values <0.05 were considered significant.
RESULTS
Polymer Characterization
By controlling reaction feed ratios, ring-opening polymerization (ROP) of lactide with a monomethoxy-capped mPEG initiator yielded mPEG-PLA with PLA block MW's of approximately 18,000 and 27,000 Da (see Table I) as  determined by 1 H-NMR. The resultant wt.% PLA, or "% PLA", defined as the ratio of PLA MW to the total diblock MW, is also shown in Table I . The GPC-determined polydispersity indices of the polymers were both 1.5. MW of the PEG block was kept constant at 5,000 Da. Polymer MW schemes were selected from previous work to formulate either spherical or filamentous PNC loaded with active catalase (15) , also outlined in Table I .
The formulation scheme for nanocarrier synthesis and protein encapsulation utilized throughout these studies, and how PEGylation of the cargo may influence this, is illustrated in Fig. 1A-F . A critical parameter of this protective cage delivery system is the diffusivity of the encapsulated enzyme's substrate through the polymer meshwork. This concept is illustrated in Fig. 1G ,H. Flux is derived from the solution to Fick's first law of diffusion for planar geometry, summarized in the following equation:
where C d and C r are donor and cumulative receptor cell concentrations, A is cross sectional area of the film at the port between the two cells, k is the partition coefficient, V is the receptor cell volume, l is the film thickness, D is the permeability coefficient, and t is time (19) . While the absolute values of each data point fluctuate from each independent experiment (Fig. 1H) , the important parameter, the slope of the corresponding trend line, D, is consistently on the same order of magnitude across all experiments. Measurement in this model showed that the normalized permeability coefficient of the catalase substrate, hydrogen peroxide, through the polymer material utilized for these formulations is on the order of 10 −9 cm 2 /s.
PEG-catalase Circulates
In Vivo Longer than Catalase, But both PEG-catalase and Catalase are Susceptible to Proteolysis
In the first series of experiments we compared free PEGcatalase with naive catalase without loading into PNC. In accord with the literature, tracing of 125 I labeled enzyme showed that PEG-catalase remains in the bloodstream at significantly higher levels than naïve catalase after intravenous injection in mice (P<0.02 at 1 min post injection and P<0.001 thereafter, Fig. 2A ). However, in vitro analysis showed that both free (non-loaded) PEG-catalase and catalase are rapidly degraded in proteolytic environments (Fig. 2B) . Thus, 1 h incubation with 0.2 wt.% pronase caused 99.0±0.8% and 97.3±0.6% loss of activity of PEG-catalase and catalase, respectively. The rate of inactivation was similarly high for both enzymes at this protease concentration, which we typically use for testing the protective effect of PNC. Further, when the protease concentrations were reduced by an order of magnitude, inactivation was still rapid with a 69.5±1.5% (catalase) and 77.8±6.6% (PEG-catalase) loss of activity within 3 h.
Utilization of PEG-catalase Enhances PNC Loading in a Freeze-Thaw Modified Formulation
We monitored loading of 125 I-labeled catalase or PEGcatalase into the nano-scale (<500 nm diameter) fraction of formulated PNC particles utilizing the methodology and analyses described in one of our recent studies (15) . Fig. 3A shows that the percent of loading by enzyme mass (defined as the percent of catalase added in the primary emulsion that is entrapped within PNC, or loading efficiency) was significantly enhanced for PEG-catalase vs catalase in both spherical Number and weight average molecular weights (M n and M w , respectively) and polydispersities (PDI, defined as M w M n ). Actual % PLA, or wt.% PLA, is defined as the ratio of the actual PLA block M n to the entire diblock copolymer M n . All diblocks contain a methoxy end-capped 5,000 MW mPEG, which served as the initiator for the ring opening polymerization (ROP) of lactide into PLA. The PNC morphology that results from the indicated polymer compositions is also noted. a Determined by 1 H-NMR b Determined by GPC (P<0.02) and filamentous PNC (P<0.001), by 200% and 100%, respectively.
Retention of enzymatic activity through particle formulation was similar for the PNC encapsulated protein, regardless of PEGylation. It should be noted that there appeared to be little impact of the PEG modification of catalase. Catalase exhibited an activity of 23.3±2.8 kU/mg of protein while PEG-catalase demonstrated 21.5±1.1 kU/mg of protein. The degree of apparent enzyme inactivation during the encapsulation within filamentous PNC was similar for catalase and PEG-catalase. Inactivation was slightly higher for PEG-catalase relative to catalase loaded into spherical PNC (Fig. 3B) . It is conceivable that redistribution of the PEG-catalase cargo from the PNC surface into the polymer matrix/PNC interior may in theory augment diffusional limitations of substrate conversion, thereby overestimating PEG-catalase inactivation (see "Discussion").
In order to quantify loaded activity, we defined percent loading as: % Loading ¼ activity recovered in PNC total activity; post formulation Â % apparent catalase inactivation ð Þ where % apparent catalase inactivation factors in activity lost during the formulation process (15) . This method of loadedcatalase quantification provides an ultimate measure of enzyme loading, i.e. total enzymatic activity associated with the PNC, taking into account formulation-induced inactivation. Thus, for both spherical and filamentous PNC, activity loading of PEG-catalase was significantly higher than that of naïve catalase (P<0.03, Fig. 3C ).
Loading of PEG-catalase Does Not Alter PNC Morphology
In previous studies, we characterized the profound effect of PEGylated diblock copolymer amphiphilicity (and thus the ratio of PEG to PLA) on PNC morphology (15) . Thus it was plausible that loading a PEG-enzyme might impact polymer control of PNC structure. Nevertheless, dynamic light scattering (DLS, Fig. 4C ) and scanning electron microscopy (SEM, Fig. 4A,B) revealed no marked impact of PEGenzyme on the size of spherical particles: i.e., the mean diameter of PNC loaded with PEG-catalase or catalase was ∼350 nm. Similarly, transmission electron microscopy (TEM) and fluorescence microscopy revealed virtually identical morphologies for filamentous PNC loaded with either PEG-catalase or catalase (Fig. 4E,F) . Cross sectional diameters varied between 60 and 70 nm for filamentous carriers with either cargo.
Final PNC concentration in the nano-scale fraction of the particles was determined by quantitative analysis of lactic acid content after complete hydrolysis of the PLA-PEG polyester carriers. Absolute mass yield is calculated based on the fact that PEG and PLA exist in equimolar amounts in the polymer backbone:
Diblock polymer mass yield
According to this analysis, there was a small, yet significant (P< 0.001) increase in mass yield of PNC loaded with PEG-catalase Fig. 3 . Enzyme mass and activity loading. Loading by mass is defined as protein mass in PNC divided by the total amount added to the particle prep during the modified emulsion formulation (A). The enzymatic activity of catalase lost during the formulation, based on kinetics of H 2 O 2 degradation (B). Percent of activity of total protein mass added is shown. Loading of catalase into mPEG-PLA PNC based on enzymatic activity (C). Black indicates PEG-catalase loading, while gray is unmodified catalase loading. Fil refers to filamentous PNC and sph refers to spherical PNC. Asterisks indicate statistically significant differences (P<0.05). compared to catalase for both filamentous and spherical carriers (Fig. 4D) . Similar to previous results (15) , the ultimate yield of filamentous carriers was higher than that of spherical PNC.
PEG-catalase Loaded in PNC is More Resistant to Proteases than Catalase Loaded in PNC
We used an in vitro test of protease inactivation to compare the kinetics of proteolytic inactivation of PEGcatalase and catalase when loaded in PNC (Fig. 5A) . Protection was determined after a 1 h incubation of the PNC in a protease solution, as this time interval was previously determined to be adequate to distinguish PNC-encapsulated enzyme protection from that of non-encapsulated enzymes (15) . PNCloaded PEG-catalase demonstrated markedly higher resistance to proteolysis than PNC-loaded catalase. This effect was most pronounced with spherical PNC, providing more than a twofold higher protection of PEG-catalase relative to catalase (P< 0.005). Filamentous PNC also provided a significantly higher protection of PEG-catalase compared to catalase (P<0.01).
PEG-catalase-PNC and Catalase-PNC Circulate in Mice
In order to test the potential utility of these formulations for intravascular drug delivery, 125 I-labeled catalase or PEGcatalase loaded within PNC were injected intravenously in mice (Fig. 5B) . Both formulations demonstrated significantly elevated levels in the blood relative to free catalase within the Fig. 4 . Morphology of PNC with different enzyme cargoes. SEM images of spherical PNC loaded with either catalase (A) or PEG-catalase (B). Scale bar is 2 μm. Sizing of spherical PNC was determined by DLS (C). Note that cat = catalase. Mass yield of PNC was determined by PLA content and all particle preps were re-suspended in 1 ml PBS (D). TEM images of filamentous PNC with either catalase (E) or PEG-catalase (F) encapsulated. Scale bar is 500 nm. Inset shows confocal fluorescence microscopy image of filamentous PNC obtained with a ×60 oil-immersion objective. Staining was with the lipophilic carbocyanine dye, PKH26 intercalated into the PNC polymer. Scale bar of inset is 5 μm. Asterisks indicate statistically significant differences (P<0.05).
first hour post injection (P<0.001). Therefore, the circulation time of PNC loaded with either enzyme demonstrate a significant improvement relative to naive catalase that is not loaded within PNC (Fig. 5B, dashed line) .
DISCUSSION
Protein drugs represent a rapidly growing area of research, yet their utility is often limited by inefficient delivery and high cost. Efficient and effective encapsulation of active therapeutic enzymes, such as catalase, into polymer nanocarriers that improve cargo delivery and protection from inhibitors and proteases may help overcome this problem. To date, the most successful attempts at encapsulation of catalytically active catalase into PNC have utilized a freezethaw modified double emulsion technique (11) . In this study we tested the hypothesis that PEG-catalase loads more efficiently than catalase into PEG-PLA PNC when such a formulation is used (Fig. 1) . This would seem to be the case as our PNC preparations of different morphologies loaded at a far higher efficiency when PEG-catalase was utilized. The same trends in both loading and protection were also observed with PNC formulated from several other different molecular weight PEG-PLA copolymers that we tested (data not shown).
The relatively mild chemical modification of enzymes appears to be a rather plausible solution to enhancing loading of potent biotherapeutics such as catalase into PNC, particularly if production of this delivery system were to reach an industrial scale. PEG modification has long been utilized in pharmaceutics to enhance aqueous solubility, stability and circulation time, as well as reduce recognition by defense systems in the body (24) (25) (26) (27) (28) (29) . PEG itself has been utilized as a stabilizer for loading small proteins (e.g., chymotrypsin, MW ∼25 kDa) into polymer microspheres (30) . Other studies examined the feasibility of covalently modifying small (on the order of 50 kDa or less) enzymes or proteins with PEG and loading of these into PLGA microspheres (31) (32) (33) (34) . PEGylation of catalase is thought to occur primarily via lysine residues, with approximately 40 molecules of PEG per molecule of enzyme (as stated by the supplier, Sigma) in the preparations used in this study. At this extent of modification, PEGylation has minimal impact on specific activity of catalase, wherein both unmodified and PEGylated catalase exhibited specific activities on the order of 20 kU/mg protein. Protocols for such chemical modifications of enzymes have long been documented in the literature (25) (26) (27) 35 ) and many PEGylated enzymes, catalase included, are commercially available, thus suggesting that this would be a relatively simple modification to implement in an industrial setting.
Our data show that use of PEG-catalase provides higher PNC loading and resistance to protease degradation than unmodified catalase. This trend was similar for both spherical and filamentous PNC, yet an interesting result of PNC morphology can be noted. For instance, while inactivation of PEG-catalase loaded into filamentous PNC was minimal and indistinguishable from that of catalase, the gain in protease resistance was less impressive than in the case of spherical PNC. This outcome suggests that there exists a limit to filamentous PNC protection of its loaded protein, possibly due to the small (∼60 nm diameter) cross section. This feature translates into a smaller protective barrier, or in other words, less polymer material between the encapsulated enzyme and any external proteases. Similarly, in the case of spherical PNC, the apparent inactivation of PEG-catalase from formulation was slightly higher than that of catalase. This apparent inactivation may be a reflection of an increase in the diffusion path length of the diffusing enzyme substrate H 2 O 2 that results from deeper encapsulation of PEG-catalase within the PNC. For enzymes deeply embedded within the PNC, the polymer thickness that must be traversed in the sphere is approximately equal to R (the radius of the sphere). However, for the filamentous PNC, this value is equal to r (the radius of the filament cross section). From analysis of the DLS and electron microscopy data, R is approximately 150 nm while r is only 30 nm. This is exacerbated when one considers possible material limitations. For instance, polymer membrane diffusion studies suggest that there may be a minor diffusion limitation for H 2 O 2 through the biomaterial matrix since the permeability coefficient through PEG-PLA is on the order of 10 −9 cm 2 /s (Fig. 1H ), compared to 10 −8 cm 2 /s (14) through a cell lipid bilayer. While this difference is small, if the utilization of PEG-catalase results in deeper embedment within the PNC, it is plausible that there may be a modest increase in diffusion barrier, i.e. access of the substrate to the encapsulated enzyme. Given the rapid kinetics of catalase activity, even a minor diffusion barrier could result in some degree of apparent inactivation. Overall, this does not seem to be a major limiting factor and is consistent with the superior resistance of PEG-catalase to protease degradation when loaded within spherical PNC.
Mechanism and consequences of the enzyme cargo inactivation are worth further studies. Inactivation may result from protein degradation or unfolding. The latter scenario seems plausible, since protein conformational changes are known to happen at solvent/water interfaces, such as those that occur with the double emulsion utilized (36) . This is in addition to the "apparent" inactivation due to diffusion limitations of the enzyme substrate that result from the encapsulating nanocarrier material itself, discussed above.
It is widely believed that PEGylation of enzymes offers many solutions to the limitations of protein therapeutics, including prolongation of circulation, facilitation of intracellular delivery and protection against inactivation (24, 25, 27, 35, (37) (38) (39) (40) (41) . Our results on prolonged circulation of PEG-catalase relative to catalase ( Fig. 2A) are consistent with the literature. However, our data show that PEG-catalase and catalase showed very similar susceptibilities to proteolysis, independent of protease concentration (Fig. 2B) . Of note, PEGylation of fibrinogen did not prevent its proteolysis (42) (43) (44) . It is conceivable that the proteolytic sensitivity of a PEG-protein depends on the nature and concentration of a protein and a protease. Perhaps at a high extent of modification multiple PEG chains can hinder protein susceptibility to proteases. Similarly, very high MW PEG chains could be grafted onto protein surfaces. These approaches were applied to dextran, where all samples were still ultimately degraded, but enzymatic degradation kinetics slowed with increasing MW and/or extent of PEG modification (45) . This PEG coating enhancement would be similar to natural sugars that are observed in the case of heavily glycosylated lysosomal enzymes. However, coupling multiple PEG chains, itself, can inactivate the modified biotherapeutics. In some instances, higher degrees of PEG modification can sacrifice enzyme stability (46) . Ultimately, PEG may serve as a kinetic barrier to proteases, yet this effect can be saturated in protease-rich environments like lysosomes. This is most evident when non-loaded PEG-catalase is compared alongside enzymes loaded within PNC that demonstrate a six to tenfold enhancement in protease resistance. Several groups studied the utility of branched PEG modified proteins (37, 39, (47) (48) (49) , yet their effectiveness in terms of protease resistance in more concentrated environments has yet to be determined. The loading of such branched-PEG enzymes into PNC has great potential and would be an interesting extension to this finding.
Spherical PNC in the sub-500 nm range are readily internalized when targeted to appropriate cell surface receptors (8) and thus are plausible candidates for intracellular delivery. Furthermore, PNC of this size circulate well enough to target specific cell types when decorated with an affinity moiety, i.e. a peptide, antibody, antibody fragment, aptamer, etc. This is evident when one notes that these PNC, without any targeting ligands, circulate on the order of hours, while similar PNC decorated with targeting antibodies traffic to their specified destination within minutes of injection (13) . Thus it would seem that the PEG-catalase-PNC, of approximately the same size as unmodified catalase-PNC, are prime candidates for systemic targeted therapeutics. Circulation studies show that there is a definite enhancement in circulation over non-loaded catalase when either PEGcatalase or catalase is encapsulated within PNC.
Further in vivo studies on asymmetrical PNC, particularly filamentous carriers are of potentially great impact, given the recent discoveries with similar systems (50, 51) . For nano filamentous carriers, there is tremendous drug loading capacity afforded by their long, micron scale length. Yet, the fact that they retain their nano status in terms of their cross sectional diameter, can result in very long circulating carriers with the potential for prolonged therapy (50) . Furthermore, their high surface area to volume ratio indicates a high potential for surface decoration with targeting epitopes relative to the carrier mass and thus has tremendous potential for drug targeting.
CONCLUSION
This study demonstrates a new application for PEGylated enzymes, namely loading within polymer nanocarriers of unique filamentous and spherical morphologies. The goal of this study was to maximize encapsulation and minimize catalase surface absorption, and thus protease accessibility to the loaded enzyme, in PNC formulations. Enzymes modified with PEG succeed in this area, as well as in enhancing protein mass loading. Thus, a simple and well characterized modification results in a therapeutic enzyme-nanocarrier delivery system well suited for intravascular delivery.
ACKNOWLEDGEMENT
This work was supported by grants from the National Institutes of Health (NIH #'s HL007954, HL073940-01-A1, HL087036 and PO1-HL079063). We thank Tony Lowman and the Centralized Materials Characterization Facility and Industry Consortium of Drexel University for assistance with NMR and SEM studies and Dennis Discher of the University of Pennsylvania for GPC studies.
